Do benefits and barriers differ by stage of adoption for colorectal cancer screening?

S. M. Rawl, U. Menon, V. L. Champion, F. E. May, P. Loehrer, C. Hunter, F. Azzouz, P. O. Monahan, C. S. Skinner

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

In 2003, over 148 300 people were expected to be diagnosed and 56 000 to die from colorectal cancer (CRC). First-degree relatives (FDRs) of people with colon cancer have a two- to eight-fold increased risk for CRC. Despite evidence that screening is effective, adherence with screening recommendations in this at-risk population is low. This study's purposes were to (1) identify perceived benefits and barriers of fecal occult blood testing (FOBT), sigmoidoscopy and colonoscopy, and (2) compare demographic characteristics and perceived benefits and barriers by stage of adoption for CRC screening. Participating FDRs (n = 257) completed a 40-min structured telephone interview. Despite high rates of agreement with the benefits of screening, most FDRs were not contemplating being screened. Of those 50 and older, most were in precontemplation for FOBT, sigmoidoscopy and colonoscopy. Older age was related to stage for FOBT and sigmoidoscopy, but not colonoscopy. Lack of provider recommendation also was related to stage. Consistent with theoretical predictions, precontemplators had (1) higher rates of endorsement of specific barriers to screening and (2) lower rates of endorsement of benefits than contemplators or actors. For morbidity and mortality reduction, participation in routine, periodic screening is imperative. These findings can guide development of screening-promoting interventions.

Original languageEnglish (US)
Pages (from-to)137-148
Number of pages12
JournalHealth Education Research
Volume20
Issue number2
DOIs
StatePublished - Apr 2005

Fingerprint

Sigmoidoscopy
Occult Blood
Colonoscopy
Early Detection of Cancer
Colorectal Neoplasms
cancer
Colonic Neoplasms
telephone interview
Demography
Interviews
morbidity
Morbidity
mortality
Mortality
participation
lack
evidence

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Education

Cite this

Do benefits and barriers differ by stage of adoption for colorectal cancer screening? / Rawl, S. M.; Menon, U.; Champion, V. L.; May, F. E.; Loehrer, P.; Hunter, C.; Azzouz, F.; Monahan, P. O.; Skinner, C. S.

In: Health Education Research, Vol. 20, No. 2, 04.2005, p. 137-148.

Research output: Contribution to journalArticle

Rawl, SM, Menon, U, Champion, VL, May, FE, Loehrer, P, Hunter, C, Azzouz, F, Monahan, PO & Skinner, CS 2005, 'Do benefits and barriers differ by stage of adoption for colorectal cancer screening?', Health Education Research, vol. 20, no. 2, pp. 137-148. https://doi.org/10.1093/her/cyg110
Rawl, S. M. ; Menon, U. ; Champion, V. L. ; May, F. E. ; Loehrer, P. ; Hunter, C. ; Azzouz, F. ; Monahan, P. O. ; Skinner, C. S. / Do benefits and barriers differ by stage of adoption for colorectal cancer screening?. In: Health Education Research. 2005 ; Vol. 20, No. 2. pp. 137-148.
@article{577cca7ac33f409ea453282edf29d5ac,
title = "Do benefits and barriers differ by stage of adoption for colorectal cancer screening?",
abstract = "In 2003, over 148 300 people were expected to be diagnosed and 56 000 to die from colorectal cancer (CRC). First-degree relatives (FDRs) of people with colon cancer have a two- to eight-fold increased risk for CRC. Despite evidence that screening is effective, adherence with screening recommendations in this at-risk population is low. This study's purposes were to (1) identify perceived benefits and barriers of fecal occult blood testing (FOBT), sigmoidoscopy and colonoscopy, and (2) compare demographic characteristics and perceived benefits and barriers by stage of adoption for CRC screening. Participating FDRs (n = 257) completed a 40-min structured telephone interview. Despite high rates of agreement with the benefits of screening, most FDRs were not contemplating being screened. Of those 50 and older, most were in precontemplation for FOBT, sigmoidoscopy and colonoscopy. Older age was related to stage for FOBT and sigmoidoscopy, but not colonoscopy. Lack of provider recommendation also was related to stage. Consistent with theoretical predictions, precontemplators had (1) higher rates of endorsement of specific barriers to screening and (2) lower rates of endorsement of benefits than contemplators or actors. For morbidity and mortality reduction, participation in routine, periodic screening is imperative. These findings can guide development of screening-promoting interventions.",
author = "Rawl, {S. M.} and U. Menon and Champion, {V. L.} and May, {F. E.} and P. Loehrer and C. Hunter and F. Azzouz and Monahan, {P. O.} and Skinner, {C. S.}",
year = "2005",
month = "4",
doi = "10.1093/her/cyg110",
language = "English (US)",
volume = "20",
pages = "137--148",
journal = "Health Education Research",
issn = "0268-1153",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Do benefits and barriers differ by stage of adoption for colorectal cancer screening?

AU - Rawl, S. M.

AU - Menon, U.

AU - Champion, V. L.

AU - May, F. E.

AU - Loehrer, P.

AU - Hunter, C.

AU - Azzouz, F.

AU - Monahan, P. O.

AU - Skinner, C. S.

PY - 2005/4

Y1 - 2005/4

N2 - In 2003, over 148 300 people were expected to be diagnosed and 56 000 to die from colorectal cancer (CRC). First-degree relatives (FDRs) of people with colon cancer have a two- to eight-fold increased risk for CRC. Despite evidence that screening is effective, adherence with screening recommendations in this at-risk population is low. This study's purposes were to (1) identify perceived benefits and barriers of fecal occult blood testing (FOBT), sigmoidoscopy and colonoscopy, and (2) compare demographic characteristics and perceived benefits and barriers by stage of adoption for CRC screening. Participating FDRs (n = 257) completed a 40-min structured telephone interview. Despite high rates of agreement with the benefits of screening, most FDRs were not contemplating being screened. Of those 50 and older, most were in precontemplation for FOBT, sigmoidoscopy and colonoscopy. Older age was related to stage for FOBT and sigmoidoscopy, but not colonoscopy. Lack of provider recommendation also was related to stage. Consistent with theoretical predictions, precontemplators had (1) higher rates of endorsement of specific barriers to screening and (2) lower rates of endorsement of benefits than contemplators or actors. For morbidity and mortality reduction, participation in routine, periodic screening is imperative. These findings can guide development of screening-promoting interventions.

AB - In 2003, over 148 300 people were expected to be diagnosed and 56 000 to die from colorectal cancer (CRC). First-degree relatives (FDRs) of people with colon cancer have a two- to eight-fold increased risk for CRC. Despite evidence that screening is effective, adherence with screening recommendations in this at-risk population is low. This study's purposes were to (1) identify perceived benefits and barriers of fecal occult blood testing (FOBT), sigmoidoscopy and colonoscopy, and (2) compare demographic characteristics and perceived benefits and barriers by stage of adoption for CRC screening. Participating FDRs (n = 257) completed a 40-min structured telephone interview. Despite high rates of agreement with the benefits of screening, most FDRs were not contemplating being screened. Of those 50 and older, most were in precontemplation for FOBT, sigmoidoscopy and colonoscopy. Older age was related to stage for FOBT and sigmoidoscopy, but not colonoscopy. Lack of provider recommendation also was related to stage. Consistent with theoretical predictions, precontemplators had (1) higher rates of endorsement of specific barriers to screening and (2) lower rates of endorsement of benefits than contemplators or actors. For morbidity and mortality reduction, participation in routine, periodic screening is imperative. These findings can guide development of screening-promoting interventions.

UR - http://www.scopus.com/inward/record.url?scp=16244362024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16244362024&partnerID=8YFLogxK

U2 - 10.1093/her/cyg110

DO - 10.1093/her/cyg110

M3 - Article

C2 - 15314036

AN - SCOPUS:16244362024

VL - 20

SP - 137

EP - 148

JO - Health Education Research

JF - Health Education Research

SN - 0268-1153

IS - 2

ER -